Fovea Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2007
Total raised
- $69M
Investors
- 7
About Fovea Pharmaceuticals
Founded in 2005 in Paris, France, Fovea Pharmaceuticals SA specializes in pharmaceuticals targeting specific medical conditions. The company underwent a significant transition in 2009 when it was acquired by Sanofi-Aventis for EUR 370 million, consolidating its position in the industry.Fovea Pharma specializes in the development and commercialization of innovative pharmaceutical products aimed at treating various medical conditions. Their core offerings include targeted therapeutics designed to address unmet medical needs in specific disease areas. The company's product portfolio focuses on enhancing patient outcomes through advanced formulations and delivery mechanisms, ensuring efficacy and safety for end users. Fovea Pharma primarily serves healthcare providers, hospitals, and specialty pharmacies, providing them with access to cutting-edge treatments.Fovea Pharma generates revenue through a structured model that encompasses partnerships, direct-to-consumer sales, and collaborations with healthcare providers. The company engages in contract agreements with hospitals and specialty pharmacies, facilitating the distribution of its flagship products to end users. Transaction structures are designed to support both B2B and B2C sales, allowing for a flexible approach in reaching various customer segments. Fovea Pharma’s pricing strategies are aligned with industry standards, ensuring competitive positioning while providing value to its clients.Fovea Pharmaceuticals plans to leverage its recent acquisition by Sanofi-Aventis to expand its product offerings and explore new markets. The company aims to introduce new therapies designed to treat niche diseases, with specific timelines for launch expected to be announced in the coming years. The strategic focus will be on enhancing its product pipeline and increasing market penetration in these regions, ensuring better access to its therapeutic solutions.
Who invested in Fovea Pharmaceuticals
7 investors across 2 rounds
See all investors in Fovea Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fovea Pharmaceuticals
Who invested in Fovea Pharmaceuticals?
Fovea Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fovea Pharmaceuticals raised?
Fovea Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fovea Pharmaceuticals last raise money?
Fovea Pharmaceuticals's most recent round on record is a Series B, in Dec 2007.
What does Fovea Pharmaceuticals do?
Founded in 2005 in Paris, France, Fovea Pharmaceuticals SA specializes in pharmaceuticals targeting specific medical conditions.
Where is Fovea Pharmaceuticals headquartered?
Fovea Pharmaceuticals is headquartered in Paris, France.
Which VCs invest in companies like Fovea Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Fovea Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Fovea Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.